Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	complement component C3b binding	CFH CFHR1 CFHR2 CFHR5 CR1	1.91e-10	12	62	5	GO:0001851
GeneOntologyMolecularFunction	opsonin binding	CFH CFHR1 CFHR2 CFHR5 CR1	1.24e-08	25	62	5	GO:0001846
GeneOntologyMolecularFunction	complement binding	CFH CFHR1 CFHR2 CFHR5 CR1	4.62e-08	32	62	5	GO:0001848
GeneOntologyMolecularFunction	monoamine oxidase activity	MAOA MAOB	2.84e-05	3	62	2	GO:0097621
GeneOntologyMolecularFunction	aliphatic amine oxidase activity	MAOA MAOB	5.67e-05	4	62	2	GO:0052595
GeneOntologyMolecularFunction	extracellular matrix structural constituent	NID2 FRAS1 RELN LAMA5 LAMB2	2.94e-04	188	62	5	GO:0005201
GeneOntologyMolecularFunction	primary methylamine oxidase activity	MAOA MAOB	3.37e-04	9	62	2	GO:0008131
GeneOntologyMolecularFunction	phosphatidylserine 1-acylhydrolase activity	LIPC PLA1A	6.14e-04	12	62	2	GO:0052739
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor	MAOA MAOB	1.11e-03	16	62	2	GO:0016641
GeneOntologyMolecularFunction	monoacylglycerol lipase activity	LIPC PNLIPRP2	1.11e-03	16	62	2	GO:0047372
GeneOntologyMolecularFunction	carboxylic ester hydrolase activity	LIPC PNLIPRP2 PLA1A ALDH2	1.44e-03	157	62	4	GO:0052689
GeneOntologyMolecularFunction	phospholipase A1 activity	LIPC PLA1A	1.57e-03	19	62	2	GO:0008970
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors	MAOA MAOB	1.74e-03	20	62	2	GO:0016638
GeneOntologyMolecularFunction	iron-sulfur cluster binding	AOX1 CMAHP ELP3	1.84e-03	78	62	3	GO:0051536
GeneOntologyMolecularFunction	metal cluster binding	AOX1 CMAHP ELP3	2.19e-03	83	62	3	GO:0051540
GeneOntologyMolecularFunction	triacylglycerol lipase activity	LIPC PNLIPRP2	2.94e-03	26	62	2	GO:0004806
GeneOntologyMolecularFunction	flavin adenine dinucleotide binding	MAOA MAOB AOX1	3.13e-03	94	62	3	GO:0050660
GeneOntologyMolecularFunction	2 iron, 2 sulfur cluster binding	AOX1 CMAHP	3.65e-03	29	62	2	GO:0051537
GeneOntologyMolecularFunction	heparan sulfate proteoglycan binding	CFH LIPC	3.65e-03	29	62	2	GO:0043395
GeneOntologyMolecularFunction	phospholipase activity	LIPC PNLIPRP2 PLA1A	5.37e-03	114	62	3	GO:0004620
GeneOntologyBiologicalProcess	complement activation	CFH CFHR1 CFHR2 CFHR5 CR1	2.00e-06	70	61	5	GO:0006956
GeneOntologyBiologicalProcess	cytolysis by host of symbiont cells	CFHR1 CFHR2 CFHR5	2.91e-06	10	61	3	GO:0051838
GeneOntologyBiologicalProcess	phenylethylamine metabolic process	MAOA MAOB	8.60e-06	2	61	2	GO:0042443
GeneOntologyBiologicalProcess	complement activation, alternative pathway	CFH CFHR5 CR1	2.31e-05	19	61	3	GO:0006957
GeneOntologyBiologicalProcess	lateral motor column neuron migration	LHX1 RELN	2.58e-05	3	61	2	GO:0097477
GeneOntologyBiologicalProcess	tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation	DPH3 ELP3	2.58e-05	3	61	2	GO:0002926
GeneOntologyBiologicalProcess	primary amino compound metabolic process	MAOA MAOB ALDH2	4.18e-05	23	61	3	GO:1901160
GeneOntologyBiologicalProcess	spinal cord motor neuron migration	LHX1 RELN	5.14e-05	4	61	2	GO:0097476
GeneOntologyBiologicalProcess	organic hydroxy compound catabolic process	GK2 MAOA MAOB ALDH2	6.47e-05	73	61	4	GO:1901616
GeneOntologyBiologicalProcess	activation of membrane attack complex	CFH CR1	1.28e-04	6	61	2	GO:0001905
GeneOntologyBiologicalProcess	regulation of complement activation, alternative pathway	CFH CR1	1.79e-04	7	61	2	GO:0030451
GeneOntologyBiologicalProcess	killing by host of symbiont cells	CFHR1 CFHR2 CFHR5	1.93e-04	38	61	3	GO:0051873
GeneOntologyBiologicalProcess	immune complex clearance	CFH CR1	3.06e-04	9	61	2	GO:0002434
GeneOntologyBiologicalProcess	dopamine catabolic process	MAOA MAOB	3.81e-04	10	61	2	GO:0042420
GeneOntologyBiologicalProcess	galactolipid metabolic process	B3GALT1 PNLIPRP2	3.81e-04	10	61	2	GO:0019374
GeneOntologyBiologicalProcess	catecholamine catabolic process	MAOA MAOB	4.65e-04	11	61	2	GO:0042424
GeneOntologyBiologicalProcess	catechol-containing compound catabolic process	MAOA MAOB	4.65e-04	11	61	2	GO:0019614
GeneOntologyCellularComponent	laminin-11 complex	LAMA5 LAMB2	2.59e-05	3	62	2	GO:0043260
GeneOntologyCellularComponent	laminin complex	LAMA5 LAMB2	3.84e-04	10	62	2	GO:0043256
GeneOntologyCellularComponent	basement membrane	NID2 FRAS1 LAMA5 LAMB2	4.74e-04	122	62	4	GO:0005604
Domain	Sushi	CFH CFHR1 CFHR2 CFHR5 CR1 CSMD3	1.71e-08	52	61	6	PF00084
Domain	CCP	CFH CFHR1 CFHR2 CFHR5 CR1 CSMD3	2.16e-08	54	61	6	SM00032
Domain	SUSHI	CFH CFHR1 CFHR2 CFHR5 CR1 CSMD3	2.70e-08	56	61	6	PS50923
Domain	Sushi_SCR_CCP_dom	CFH CFHR1 CFHR2 CFHR5 CR1 CSMD3	3.01e-08	57	61	6	IPR000436
Domain	Lipase/vitellogenin	LIPC PNLIPRP2 PLA1A	3.91e-06	10	61	3	IPR013818
Domain	TAG_lipase	LIPC PNLIPRP2 PLA1A	3.91e-06	10	61	3	IPR000734
Domain	Lipase_LIPH	LIPC PNLIPRP2 PLA1A	3.91e-06	10	61	3	IPR016272
Domain	Lipase	LIPC PNLIPRP2 PLA1A	3.91e-06	10	61	3	PF00151
Domain	Lipase_N	LIPC PNLIPRP2 PLA1A	3.91e-06	10	61	3	IPR033906
Domain	Flavin_amine_oxidase	MAOA MAOB	3.14e-05	3	61	2	IPR001613
Domain	LIPASE_SER	LIPC PNLIPRP2 PLA1A	8.17e-05	26	61	3	PS00120
Domain	EGF	NID2 FRAS1 RELN CNTNAP4 LAMA5 LAMB2	1.16e-04	235	61	6	SM00181
Domain	EGF-like_dom	NID2 FRAS1 RELN CNTNAP4 LAMA5 LAMB2	1.59e-04	249	61	6	IPR000742
Domain	Amino_oxidase	MAOA MAOB	4.64e-04	10	61	2	IPR002937
Domain	Amino_oxidase	MAOA MAOB	4.64e-04	10	61	2	PF01593
Domain	CUB	PDGFC CSMD3 ADGRG6	5.49e-04	49	61	3	PF00431
Domain	CUB	PDGFC CSMD3 ADGRG6	5.82e-04	50	61	3	SM00042
Domain	-	PDGFC CSMD3 ADGRG6	6.54e-04	52	61	3	2.60.120.290
Domain	CUB	PDGFC CSMD3 ADGRG6	6.91e-04	53	61	3	PS01180
Domain	ConA-like_dom	CNTNAP4 LAMA5 HNRNPUL1 RYR2 ADGRG6	7.39e-04	219	61	5	IPR013320
Domain	CUB_dom	PDGFC CSMD3 ADGRG6	8.56e-04	57	61	3	IPR000859
Domain	Laminin_N	LAMA5 LAMB2	1.22e-03	16	61	2	IPR008211
Domain	LAMININ_NTER	LAMA5 LAMB2	1.22e-03	16	61	2	PS51117
Domain	Laminin_N	LAMA5 LAMB2	1.22e-03	16	61	2	PF00055
Domain	LamNT	LAMA5 LAMB2	1.22e-03	16	61	2	SM00136
Domain	LH2	LIPC PNLIPRP2	1.55e-03	18	61	2	SM00308
Domain	EGF-like_CS	NID2 RELN CNTNAP4 LAMA5 LAMB2	1.61e-03	261	61	5	IPR013032
Domain	Growth_fac_rcpt_	NID2 FRAS1 LAMA5 LAMB2	1.69e-03	156	61	4	IPR009030
Domain	EGF_2	NID2 RELN CNTNAP4 LAMA5 LAMB2	1.72e-03	265	61	5	PS01186
Domain	PLAT	LIPC PNLIPRP2	2.12e-03	21	61	2	PS50095
Domain	-	LIPC PNLIPRP2	2.12e-03	21	61	2	2.60.60.20
Domain	PLAT	LIPC PNLIPRP2	2.12e-03	21	61	2	PF01477
Domain	PLAT/LH2_dom	LIPC PNLIPRP2	2.12e-03	21	61	2	IPR001024
Domain	Galactose-bd-like	CNTNAP4 LAMA5 LAMB2	3.60e-03	94	61	3	IPR008979
Domain	-	CNTNAP4 LAMA5 ADGRG6	3.71e-03	95	61	3	2.60.120.200
Domain	EGF_LAM_2	LAMA5 LAMB2	4.30e-03	30	61	2	PS50027
Domain	EGF_LAM_1	LAMA5 LAMB2	4.30e-03	30	61	2	PS01248
Domain	Laminin_EGF	LAMA5 LAMB2	5.83e-03	35	61	2	PF00053
Domain	EGF_Lam	LAMA5 LAMB2	5.83e-03	35	61	2	SM00180
Domain	LAM_G_DOMAIN	CNTNAP4 LAMA5	6.84e-03	38	61	2	PS50025
Domain	Laminin_EGF	LAMA5 LAMB2	6.84e-03	38	61	2	IPR002049
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR	CFH CFHR1 CFHR2 CFHR5	1.23e-09	6	44	4	M47880
Pathway	KEGG_GLYCEROLIPID_METABOLISM	LIPC GK2 GLA PNLIPRP2 ALDH2	4.04e-07	49	44	5	M15902
Pathway	WP_TRYPTOPHAN_METABOLISM	MAOA AOX1 ALDH2 GOT2	3.16e-06	33	44	4	M39500
Pathway	KEGG_TRYPTOPHAN_METABOLISM	MAOA MAOB AOX1 ALDH2	6.95e-06	40	44	4	M980
Pathway	KEGG_TYROSINE_METABOLISM	MAOA MAOB AOX1 GOT2	8.47e-06	42	44	4	M16743
Pathway	KEGG_PHENYLALANINE_METABOLISM	MAOA MAOB GOT2	2.24e-05	18	44	3	M16650
Pathway	KEGG_ARGININE_AND_PROLINE_METABOLISM	MAOA MAOB ALDH2 GOT2	2.33e-05	54	44	4	M2551
Pathway	REACTOME_COMPLEMENT_CASCADE	CFH CFHR1 CFHR2 CFHR5 CR1	2.79e-05	115	44	5	M19752
Pathway	KEGG_MEDICUS_REFERENCE_ALTERNATIVE_PATHWAY_OF_COMPLEMENT_CASCADE_C3B_BREAKDOWN	CFH CR1	9.46e-05	5	44	2	M47875
Pathway	KEGG_MEDICUS_REFERENCE_SEROTONIN_METABOLISM	MAOA MAOB	9.46e-05	5	44	2	M47902
Pathway	KEGG_HISTIDINE_METABOLISM	MAOA MAOB ALDH2	9.80e-05	29	44	3	M12524
Pathway	REACTOME_LAMININ_INTERACTIONS	NID2 LAMA5 LAMB2	1.09e-04	30	44	3	M27216
Pathway	WP_COMPLEMENT_SYSTEM	CFH CFHR2 LAMA5 CR1	2.23e-04	96	44	4	M39581
Pathway	REACTOME_NEUROTRANSMITTER_CLEARANCE	MAOA ALDH2	2.63e-04	8	44	2	MM14500
Pathway	WP_FOCAL_ADHESION	FLNB RELN LAMA5 LAMB2 PDGFC	3.70e-04	199	44	5	M39402
Pathway	KEGG_FOCAL_ADHESION	FLNB RELN LAMA5 LAMB2 PDGFC	3.70e-04	199	44	5	M7253
Pathway	WP_TRYPTOPHAN_METABOLISM	MAOB AOX1 ALDH2	4.45e-04	48	44	3	MM15902
Pathway	PID_INTEGRIN4_PATHWAY	LAMA5 LAMB2	5.14e-04	11	44	2	M158
Pathway	REACTOME_NEUROTRANSMITTER_CLEARANCE	MAOA ALDH2	5.14e-04	11	44	2	M26914
Pathway	WP_DOPAMINE_METABOLISM	MAOA MAOB	7.27e-04	13	44	2	M39622
Pathway	WP_SIDS_SUSCEPTIBILITY_PATHWAYS	MAOA RORA RYR2	8.16e-04	59	44	3	MM15838
Pathway	WP_ADHD_AND_AUTISM_ASD_PATHWAYS	MAOA MAOB AOX1 CNTNAP4 ALDH2 GOT2	9.14e-04	367	44	6	M48346
Pathway	WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE	MAOA MAOB	9.74e-04	15	44	2	M45537
Pathway	REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	RORA PPARA	1.41e-03	18	44	2	M26942
Pathway	WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS	LAMA5 LAMB2 CR1	1.46e-03	72	44	3	M39403
Pathway	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	MAOA MAOB AOX1	1.46e-03	72	44	3	M9257
Pathway	WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS	LAMA5 LAMB2 CR1	1.52e-03	73	44	3	MM15906
Pathway	WP_GLYCOSPHINGOLIPID_METABOLISM	B3GALT1 GLA	1.93e-03	21	44	2	M46462
Pathway	REACTOME_COMPLEMENT_CASCADE	CFH CFHR1 CFHR2	2.27e-03	84	44	3	MM14653
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	RELN LAMA5 LAMB2	2.27e-03	84	44	3	M7098
Pathway	WP_TRIACYLGLYCERIDE_SYNTHESIS	LIPC GK2	2.31e-03	23	44	2	MM15890
Pathway	WP_TRIACYLGLYCERIDE_SYNTHESIS	LIPC GK2	2.52e-03	24	44	2	M39692
Pubmed	Dimerization of complement factor H-related proteins modulates complement activation in vivo.	CFH CFHR1 CFHR2 CFHR5	1.37e-10	6	62	4	23487775
Pubmed	Sequence and Expression of Complement Factor H Gene Cluster Variants and Their Roles in Age-Related Macular Degeneration Risk.	CFH CFHR1 CFHR2 CFHR5	1.37e-10	6	62	4	27196323
Pubmed	Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications.	CFH CFHR1 CFHR2 CFHR5	1.37e-10	6	62	4	17438673
Pubmed	Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome.	CFH CFHR1 CFHR2 CFHR5	1.15e-09	9	62	4	20059470
Pubmed	C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.	CFHR1 CFHR2 CFHR5	5.39e-09	3	62	3	23728178
Pubmed	Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.	CFH CFHR1 CFHR2	2.16e-08	4	62	3	24333077
Pubmed	Complement factor H and related proteins: an expanding family of complement-regulatory proteins?	CFH CFHR1 CFHR2	5.38e-08	5	62	3	8172644
Pubmed	Factor H-related proteins determine complement-activating surfaces.	CFHR1 CFHR2 CFHR5	5.38e-08	5	62	3	25979655
Pubmed	Identification and sequence analysis of four complement factor H-related transcripts in mouse liver.	CFH CFHR1 CFHR2	5.38e-08	5	62	3	1689298
Pubmed	A radiation hybrid map of complement factor H and factor H-related genes.	CFH CFHR1 CFHR2	5.38e-08	5	62	3	10380701
Pubmed	A synaptic nidogen: developmental regulation and role of nidogen-2 at the neuromuscular junction.	NID2 LAMA5 LAMB2	1.07e-07	6	62	3	18817539
Pubmed	The NEI/NCBI dbGAP database: genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration.	CFH CFHR2 CFHR5	1.07e-07	6	62	3	18541031
Pubmed	Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.	NID2 FRAS1 LAMA5 LAMB2	2.10e-07	29	62	4	22613833
Pubmed	Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.	CFH CFHR1 CFHR5 CR1	2.78e-07	31	62	4	19344414
Pubmed	C3 Glomerulopathy	CFH CFHR1 CFHR5	3.00e-07	8	62	3	20301598
Pubmed	FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation.	CFH CFHR1 CFHR5	4.50e-07	9	62	3	28533443
Pubmed	Basement membrane composition in the early mouse embryo day 7.	NID2 LAMA5 LAMB2	2.42e-06	15	62	3	15895400
Pubmed	Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.	MAOA MAOB	3.13e-06	2	62	2	29050386
Pubmed	Deregulation of Factor H by Factor H-Related Protein 1 Depends on Sialylation of Host Surfaces.	CFH CFHR1	3.13e-06	2	62	2	33732239
Pubmed	Deficiency of Mouse FHR-1 Homolog, FHR-E, Accelerates Sepsis, and Acute Kidney Injury Through Enhancing the LPS-Induced Alternative Complement Pathway.	CFHR1 CFHR2	3.13e-06	2	62	2	32636836
Pubmed	Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans.	MAOA MAOB	3.13e-06	2	62	2	19657584
Pubmed	Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.	MAOA MAOB	3.13e-06	2	62	2	21971001
Pubmed	Structural properties of human monoamine oxidases A and B.	MAOA MAOB	3.13e-06	2	62	2	21971000
Pubmed	Sex-dependent monoamine oxidase isoforms expression patterns during human brain ageing.	MAOA MAOB	3.13e-06	2	62	2	34097937
Pubmed	Differential age-related changes of MAO-A and MAO-B in mouse brain and peripheral organs.	MAOA MAOB	3.13e-06	2	62	2	7969716
Pubmed	Neonatal vestibular stimulation and mating in cerebellar mutants.	RELN RORA	3.13e-06	2	62	2	8352721
Pubmed	The FAD binding sites of human monoamine oxidases A and B.	MAOA MAOB	3.13e-06	2	62	2	14697881
Pubmed	Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).	CFH CFHR5	3.13e-06	2	62	2	16299065
Pubmed	Cognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice.	MAOA MAOB	3.13e-06	2	62	2	23858446
Pubmed	Human liver MAO-A and MAO-B separated by immunoaffinity chromatography with MAO-B-specific monoclonal antibody.	MAOA MAOB	3.13e-06	2	62	2	7063850
Pubmed	Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography.	MAOA MAOB	3.13e-06	2	62	2	21075085
Pubmed	Which genotype of MAO gene that the patients have are likely to be most susceptible to the symptoms of fibromyalgia?	MAOA MAOB	3.13e-06	2	62	2	17885758
Pubmed	Association of V227A PPARalpha polymorphism with altered serum biochemistry and alcohol drinking in Japanese men.	PPARA ALDH2	3.13e-06	2	62	2	16847426
Pubmed	Inhibition of Excessive Monoamine Oxidase A/B Activity Protects Against Stress-induced Neuronal Death in Huntington Disease.	MAOA MAOB	3.13e-06	2	62	2	25398695
Pubmed	Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration.	CFHR2 CFHR5	3.13e-06	2	62	2	34260947
Pubmed	Molecular cloning of a human serum protein structurally related to complement factor H.	CFHR1 CFHR2	3.13e-06	2	62	2	1711047
Pubmed	MAO-A and -B gene knock-out mice exhibit distinctly different behavior.	MAOA MAOB	3.13e-06	2	62	2	10591056
Pubmed	Transcriptional regulation and multiple functions of MAO genes.	MAOA MAOB	3.13e-06	2	62	2	21359973
Pubmed	Gene Influence in the Effectiveness of Plant Sterols Treatment in Children: Pilot Interventional Study.	LIPC PPARA	3.13e-06	2	62	2	31640222
Pubmed	Interaction between complement regulators and Streptococcus pyogenes: binding of C4b-binding protein and factor H/factor H-like protein 1 to M18 strains involves two different cell surface molecules.	CFH CFHR1	3.13e-06	2	62	2	15557185
Pubmed	Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome.	CFH CFHR1	3.13e-06	2	62	2	21677636
Pubmed	Association study of monoamine oxidase A/B genes and schizophrenia in Han Chinese.	MAOA MAOB	3.13e-06	2	62	2	21978760
Pubmed	Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline.	MAOA MAOB	3.13e-06	2	62	2	28577058
Pubmed	Assignment of genes for human monoamine oxidases A and B to the X chromosome.	MAOA MAOB	3.13e-06	2	62	2	3540317
Pubmed	Factor H and CFHR1 polymorphisms associated with atypical Haemolytic Uraemic Syndrome (aHUS) are differently expressed in Tunisian and in Caucasian populations.	CFH CFHR1	3.13e-06	2	62	2	22136554
Pubmed	Deciphering the ligand-binding sites in the Borrelia burgdorferi complement regulator-acquiring surface protein 2 required for interactions with the human immune regulators factor H and factor H-like protein 1.	CFH CFHR1	3.13e-06	2	62	2	18824548
Pubmed	Protein phosphatase mRNA expression in Purkinje cells of staggerer and reeler mutant mice.	RELN RORA	3.13e-06	2	62	2	8774953
Pubmed	Human monoamine oxidase A and B genes exhibit identical exon-intron organization.	MAOA MAOB	3.13e-06	2	62	2	2023912
Pubmed	Analysis of conserved active site residues in monoamine oxidase A and B and their three-dimensional molecular modeling.	MAOA MAOB	3.13e-06	2	62	2	11861643
Pubmed	human monoamine oxidase (hMAO) A and hMAO B inhibitors from Artemisia dracunculus L. herniarin and skimmin: human mononamine oxidase A and B inhibitors from A. dracunculus L.	MAOA MAOB	3.13e-06	2	62	2	32598328
Pubmed	Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases.	CFHR1 CFHR2	3.13e-06	2	62	2	33651882
Pubmed	Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS.	CFH CFHR1	3.13e-06	2	62	2	20865640
Pubmed	A synthetic protein as efficient multitarget regulator against complement over-activation.	CFH CFHR1	3.13e-06	2	62	2	35194132
Pubmed	Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.	CFH CFHR1	3.13e-06	2	62	2	23243267
Pubmed	Complement factor H-related hybrid protein deregulates complement in dense deposit disease.	CFHR2 CFHR5	3.13e-06	2	62	2	24334459
Pubmed	The genotypes and methylation of MAO genes as factors behind smoking behavior.	MAOA MAOB	3.13e-06	2	62	2	28858992
Pubmed	Complement Factor H-Related Proteins FHR1 and FHR5 Interact With Extracellular Matrix Ligands, Reduce Factor H Regulatory Activity and Enhance Complement Activation.	CFHR1 CFHR5	3.13e-06	2	62	2	35392081
Pubmed	Monoamine oxidase A and A/B knockout mice display autistic-like features.	MAOA MAOB	3.13e-06	2	62	2	22850464
Pubmed	Monoamine oxidase A gene polymorphism predicts adolescent outcome of attention-deficit/hyperactivity disorder.	MAOA MAOB	3.13e-06	2	62	2	17427196
Pubmed	Cloning of the 1.4-kb mRNA species of human complement factor H reveals a novel member of the short consensus repeat family related to the carboxy terminal of the classical 150-kDa molecule.	CFH CFHR1	3.13e-06	2	62	2	1826708
Pubmed	Selective Interactions of O-Methylated Flavonoid Natural Products with Human Monoamine Oxidase-A and -B.	MAOA MAOB	3.13e-06	2	62	2	33212830
Pubmed	Comparison of the structural properties of the active site cavities of human and rat monoamine oxidase A and B in their soluble and membrane-bound forms.	MAOA MAOB	3.13e-06	2	62	2	18092818
Pubmed	Deletion of MAOA and MAOB in a male patient causes severe developmental delay, intermittent hypotonia and stereotypical hand movements.	MAOA MAOB	3.13e-06	2	62	2	20485326
Pubmed	Association analysis of the functional MAOA gene promoter and MAOB gene intron 13 polymorphisms in tension type headache patients.	MAOA MAOB	3.13e-06	2	62	2	25618115
Pubmed	Association study between antipsychotic-induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophrenia.	MAOA MAOB	3.13e-06	2	62	2	20589923
Pubmed	Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome.	CFH CFHR1	3.13e-06	2	62	2	22894814
Pubmed	Monoamine oxidase polymorphisms and smoking behaviour in Japanese.	MAOA MAOB	3.13e-06	2	62	2	12563176
Pubmed	Selectivity of Dietary Phenolics for Inhibition of Human Monoamine Oxidases A and B.	MAOA MAOB	3.13e-06	2	62	2	30809547
Pubmed	MAOA-uVNTR polymorphism may modify the protective effect of ALDH2 gene against alcohol dependence in antisocial personality disorder.	MAOA ALDH2	3.13e-06	2	62	2	19302089
Pubmed	Monoamine oxidase a expression is vital for embryonic brain development by modulating developmental apoptosis.	MAOA MAOB	3.13e-06	2	62	2	21697081
Pubmed	Human complement factor H and factor H-like protein 1 are expressed in human retinal pigment epithelial cells.	CFH CFHR1	3.13e-06	2	62	2	24280833
Pubmed	Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy.	CFHR1 CFHR5	3.13e-06	2	62	2	28673452
Pubmed	Increased baroreceptor response in mice deficient in monoamine oxidase A and B.	MAOA MAOB	3.13e-06	2	62	2	11834493
Pubmed	A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome.	CFH CFHR1	3.13e-06	2	62	2	23880784
Pubmed	Influence of the environment on the oxidative deamination of p-substituted benzylamines in monoamine oxidase.	MAOA MAOB	3.13e-06	2	62	2	25671411
Pubmed	Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels.	CFH CFHR1	3.13e-06	2	62	2	20855886
Pubmed	cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.	MAOA MAOB	3.13e-06	2	62	2	3387449
Pubmed	Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease.	MAOA MAOB	3.13e-06	2	62	2	17044053
Pubmed	Site-directed mutagenesis of monoamine oxidase A and B: role of cysteines.	MAOA MAOB	3.13e-06	2	62	2	8316221
Pubmed	Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation.	SPEG RYR2	3.13e-06	2	62	2	32683896
Pubmed	Association between monoamine oxidase gene polymorphisms and smoking behavior: A meta-analysis.	MAOA MAOB	3.13e-06	2	62	2	26051160
Pubmed	Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B.	MAOA MAOB	3.13e-06	2	62	2	16129825
Pubmed	A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior.	MAOA MAOB	3.13e-06	2	62	2	15272015
Pubmed	Promoter organization and activity of human monoamine oxidase (MAO) A and B genes.	MAOA MAOB	3.13e-06	2	62	2	1432104
Pubmed	Monoamine oxidase and agitation in psychiatric patients.	MAOA MAOB	3.13e-06	2	62	2	26851573
Pubmed	Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.	CFH CFHR1	3.13e-06	2	62	2	23938460
Pubmed	A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.	CFHR1 CFHR5	3.13e-06	2	62	2	28729035
Pubmed	Monoamine oxidases A and B gene polymorphisms in migraine patients.	MAOA MAOB	3.13e-06	2	62	2	15694196
Pubmed	Structural comparison of human monoamine oxidases A and B: mass spectrometry monitoring of cysteine reactivities.	MAOA MAOB	3.13e-06	2	62	2	12777388
Pubmed	Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration.	CFH CFHR1	3.13e-06	2	62	2	23873044
Pubmed	The influence of monoamine oxidase variants on the risk of betel quid-associated oral and pharyngeal cancer.	MAOA MAOB	3.13e-06	2	62	2	25389533
Pubmed	Pilot study indicate role of preferentially transmitted monoamine oxidase gene variants in behavioral problems of male ADHD probands.	MAOA MAOB	3.13e-06	2	62	2	28982350
Pubmed	Substrates but not inhibitors alter the redox potentials of monoamine oxidases.	MAOA MAOB	3.13e-06	2	62	2	11761322
Pubmed	Evidence for a genetic association between monoamine oxidase A and restless legs syndrome.	MAOA MAOB	3.13e-06	2	62	2	12136060
Pubmed	Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups.	MAOA MAOB	3.13e-06	2	62	2	14962671
Pubmed	CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome.	CFH CFHR1	3.13e-06	2	62	2	36755127
Pubmed	Assignment of complement components C4 binding protein (C4BP) and factor H (FH) to human chromosome 1q, using cDNA probes.	CFH CR1	3.13e-06	2	62	2	2977721
Pubmed	Monoamine Oxidase Deficiency Causes Prostate Atrophy and Reduces Prostate Progenitor Cell Activity.	MAOA MAOB	3.13e-06	2	62	2	29637670
Pubmed	Monoamine oxidase: from genes to behavior.	MAOA MAOB	3.13e-06	2	62	2	10202537
Pubmed	The oxidation of adrenaline and noradrenaline by the two forms of monoamine oxidase from human and rat brain.	MAOA MAOB	3.13e-06	2	62	2	20493079
Interaction	CFHR1 interactions	CFH CFHR1 CFHR2	9.62e-07	7	62	3	int:CFHR1
Interaction	CFHR2 interactions	CFHR1 CFHR2	2.79e-05	3	62	2	int:CFHR2
Cytoband	Ensembl 112 genes in cytogenetic band chr1q31	CFH CFHR1 CFHR2 CFHR5	3.41e-06	75	62	4	chr1q31
Cytoband	1q32	CFH CFHR1 CR1	4.13e-05	49	62	3	1q32
Cytoband	1q31.3	CFHR2 CFHR5	2.13e-04	16	62	2	1q31.3
Cytoband	13q34	NAXD TMEM255B	2.45e-03	54	62	2	13q34
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CFH CFHR1 CFHR2 CFHR5 CR1 CSMD3	2.25e-09	57	39	6	1179
GeneFamily	Complement system\|Sushi domain containing	CFH CFHR1 CFHR2 CFHR5 CR1	1.28e-08	36	39	5	492
GeneFamily	Laminin subunits	LAMA5 LAMB2	2.95e-04	12	39	2	626
GeneFamily	Lipases\|Arylacetamide deacetylase family	LIPC PNLIPRP2	1.02e-03	22	39	2	464
GeneFamily	Nuclear hormone receptors	RORA PPARA	5.00e-03	49	39	2	71
Coexpression	SERVITJA_LIVER_HNF1A_TARGETS_DN	CFH SLC41A2 FRAS1 PLA1A CMAHP PDGFC	2.22e-06	166	60	6	M2398
Coexpression	SERVITJA_LIVER_HNF1A_TARGETS_DN	CFH SLC41A2 FRAS1 PLA1A CMAHP PDGFC	4.85e-06	190	60	6	MM1311
Coexpression	AIZARANI_LIVER_C11_HEPATOCYTES_1	CFH CFHR1 LIPC MAOB PTGR1 AOX1 ALDH2	5.28e-06	298	60	7	M39115
Coexpression	HSIAO_LIVER_SPECIFIC_GENES	CFH CFHR2 LIPC PTGR1 AOX1 ALDH2	2.26e-05	249	60	6	M13283
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	CFH KLHL24 AOX1 RORA	2.27e-05	72	60	4	M15699
Coexpression	DESCARTES_ORGANOGENESIS_HEPATOCYTES	SEC16B LIPC PNLIPRP2 MAOB PLA1A PPARA SLC16A12 GOT2	2.88e-05	535	60	8	MM3635
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	CFH KLHL24 AOX1 RORA	3.12e-05	78	60	4	MM867
Coexpression	HOSHIDA_LIVER_CANCER_SUBCLASS_S3	CFH MAOA MAOB PTGR1 ALDH2 GOT2	3.27e-05	266	60	6	M1286
Coexpression	HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL	NID2 RELN MAOB LAMB2 PPARA PDGFC	3.41e-05	268	60	6	M45796
Coexpression	LI_CISPLATIN_RESISTANCE_DN	CFH CFHR1 ADGRG6	5.92e-05	33	60	3	M10150
Coexpression	NABA_ECM_GLYCOPROTEINS	NID2 FRAS1 RELN LAMA5 LAMB2	7.69e-05	191	60	5	MM17059
Coexpression	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	CFH ORC5 FLNB KLHL24 EFHC1 SPIB ALDH2	8.60e-05	461	60	7	M14127
Coexpression	NABA_ECM_GLYCOPROTEINS	NID2 FRAS1 RELN LAMA5 LAMB2	8.69e-05	196	60	5	M3008
Coexpression	GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN	SLC41A2 SEC16B KLHL24 RELN PTGR1	9.56e-05	200	60	5	M8956
Coexpression	GSE7852_THYMUS_VS_FAT_TREG_DN	SLC41A2 NID2 SEC16B FLNB RORA	9.56e-05	200	60	5	M5744
Coexpression	OHGUCHI_LIVER_HNF4A_TARGETS_DN	B3GALT1 CFHR1 CFHR2 LIPC CMAHP	9.78e-05	201	60	5	MM1294
Coexpression	NABA_BASEMENT_MEMBRANES	NID2 LAMA5 LAMB2	1.06e-04	40	60	3	M5887
Coexpression	HEVNER_CORTEX_CAJAL_RETZIUS_CELLS	LHX1 RELN	1.43e-04	8	60	2	MM394
Coexpression	CAIRO_LIVER_DEVELOPMENT_DN	CFH LIPC MAOB PLA1A PPARA	1.66e-04	225	60	5	M6175
Coexpression	HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN	RELN LIPC PTGR1	1.83e-04	48	60	3	M4655
Coexpression	CAIRO_LIVER_DEVELOPMENT_DN	CFH LIPC MAOB PLA1A PPARA	2.19e-04	239	60	5	MM1274
CoexpressionAtlas	liver	CFH CFHR1 CFHR2 RELN LIPC AOX1 CFHR5 SEC14L4	2.24e-05	419	60	8	liver
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500	B3GALT1 SLCO5A1 KLHL24 MAOA PNLIPRP2 CNTNAP4 CSMD3 RYR2	2.57e-05	427	60	8	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_1000	SLC41A2 SEC16B MAOB PLA1A PTGR1 AOX1 ALDH2 CMAHP CSMD3 SLC16A12	6.23e-05	783	60	10	gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000
CoexpressionAtlas	dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	B3GALT1 SLC41A2 PNLIPRP2 MAOB PTGR1 PPARA ALDH2 CSMD3 NEXN RYR2	7.68e-05	803	60	10	gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	B cells, B.FrE.BM, CD19+ IgM+ AA4.1+ HSA+, Bone marrow, avg-3	SLCO5A1 SLC41A2 KLHL24 RELN FCRL1 SPIB CMAHP	8.89e-05	376	60	7	GSM399438_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	MKRN3 B3GALT1 SLCO5A1 KLHL24 MAOA PNLIPRP2 MAOB CNTNAP4 CSMD3 RYR2	8.95e-05	818	60	10	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500	SLC41A2 PLA1A AOX1 RORA ALDH2 NEXN SLC16A12	9.19e-05	378	60	7	gudmap_developingLowerUrinaryTract_adult_bladder_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000	B3GALT1 SLCO5A1 NID2 EFHC1 PNLIPRP2 PLA1A CMAHP PDGFC NEXN RYR2	1.08e-04	837	60	10	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000
CoexpressionAtlas	kidney_e15.5_Podocyte_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	CFH FRAS1 NEXN ADGRG6	1.23e-04	90	60	4	gudmap_kidney_e15.5_Podocyte_MafB_k2_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#5_top-relative-expression-ranked_1000	RORA ALDH2 NEXN RYR2	1.34e-04	92	60	4	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500	MKRN3 B3GALT1 SLCO5A1 SEC16B MAOB NEXN RYR2	1.82e-04	422	60	7	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000	SLC41A2 PLA1A AOX1 RORA ALDH2 NEXN SLC16A12 RYR2 ADGRG6	2.05e-04	734	60	9	gudmap_developingLowerUrinaryTract_adult_bladder_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#3_top-relative-expression-ranked_500	SLC41A2 AOX1 RORA ALDH2	2.07e-04	103	60	4	gudmap_developingLowerUrinaryTract_adult_bladder_500_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000	B3GALT1 SLC41A2 PLA1A SPEG AOX1 ALDH2 FAM118A NEXN RYR2	2.67e-04	761	60	9	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#3_top-relative-expression-ranked_1000	SLC41A2 AOX1 RORA ALDH2 RYR2	3.03e-04	208	60	5	gudmap_developingLowerUrinaryTract_adult_bladder_1000_k3
CoexpressionAtlas	kidney_adult_RenalCapsule_top-relative-expression-ranked_1000	CFH NID2 FRAS1 AOX1 LAMB2 CMAHP PDGFC NEXN ADGRG6	3.15e-04	778	60	9	gudmap_kidney_adult_RenalCapsule_1000
CoexpressionAtlas	dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_1000	B3GALT1 MAOA MAOB CSMD3 ADGRG6	3.24e-04	211	60	5	gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_1000
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	B3GALT1 SLC41A2 MAOA PNLIPRP2 MAOB PTGR1 PPARA CSMD3 RYR2	3.55e-04	791	60	9	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#1_top-relative-expression-ranked_1000	MAOA PNLIPRP2 MAOB CNTNAP4 CSMD3	3.68e-04	217	60	5	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k1_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000	SLC41A2 GLA MAOA PNLIPRP2 MAOB PTGR1 PDGFC NEXN RYR2	3.75e-04	797	60	9	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_500	MAOA PNLIPRP2 CNTNAP4 CSMD3	4.59e-04	127	60	4	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000	MKRN3 B3GALT1 SLCO5A1 SEC16B MAOA MAOB NEXN RYR2 ADGRG6	4.87e-04	826	60	9	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000	MKRN3 B3GALT1 SLCO5A1 PNLIPRP2 CNTNAP4 RORA ALDH2 NEXN RYR2	4.91e-04	827	60	9	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFH FRAS1 MAOB AOX1 RORA NEXN SLC16A12 RYR2	2.53e-10	191	62	8	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFH FRAS1 MAOB AOX1 RORA NEXN SLC16A12 RYR2	2.64e-10	192	62	8	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CFH NID2 FRAS1 LIPC SLC16A12 ADGRG6	1.28e-07	168	62	6	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 FCRL1 SPIB CNTNAP4 CSMD3 RYR2	1.63e-07	175	62	6	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	FRAS1 MAOB RORA NEXN SLC16A12 RYR2	2.41e-07	187	62	6	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAOB SPEG PDGFC NEXN RYR2 ADGRG6	2.49e-07	188	62	6	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	Control-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	CFH MAOB AOX1 RORA NEXN RYR2	2.99e-07	194	62	6	3c2266772c5b56e8e02a461e5193e29588028ee9
ToppCell	Control-Stromal-Myofibroblast\|Control / Disease state, Lineage and Cell class	CFH MAOB AOX1 RORA NEXN RYR2	3.08e-07	195	62	6	ffcf76cd72e43d8cf1058a49c76e0956065038bc
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	MAOB AOX1 RORA NEXN SLC16A12 RYR2	3.08e-07	195	62	6	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	CFH FRAS1 MAOB AOX1 RORA RYR2	3.37e-07	198	62	6	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFH MAOB AOX1 RORA NEXN RYR2	3.37e-07	198	62	6	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Fetal_29-31_weeks\|World / Lineage, Cell type, age group and donor	CFH NID2 FRAS1 RORA RYR2 ADGRG6	3.47e-07	199	62	6	5b9d355795dd03a22f0961dfd143425c367a4654
ToppCell	Tracheal-NucSeq-Stromal-Schwann-Schwann_Myelinating\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MKRN3 RELN LIPC DPH3 CNTNAP4 CR1	3.47e-07	199	62	6	4e4bdcd2e8b518156d5ebd294804180acaa3566b
ToppCell	facs-Liver-Hepatocytes-3m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFHR1 CFHR2 SEC16B LIPC MAOB	1.47e-06	139	62	5	82bf5ba69a907fbd9b4e2b2dd1dd27b8c4c75f25
ToppCell	facs-Liver-Hepatocytes-3m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFHR1 CFHR2 SEC16B LIPC MAOB	1.47e-06	139	62	5	fc9ac09c2106e88104a52575832d71d17765eec8
ToppCell	facs-Liver-Hepatocytes-3m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFHR1 CFHR2 SEC16B LIPC MAOB	1.47e-06	139	62	5	fc4b39ac9a10cf0acacfebbc4295edf324d930d5
ToppCell	facs-Liver-Hepatocytes-3m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFHR1 CFHR2 SEC16B LIPC MAOB	1.47e-06	139	62	5	4ddfbc36a0560fb70594627178bff652ab1ea3e9
ToppCell	ileum-BEST4+_Enterocytes\|ileum / shred on tissue and cell subclass	NID2 GLA PLA1A CMAHP ADGRG6	2.43e-06	154	62	5	608e9c982125e0c2c15b86b1920813845a0db81f
ToppCell	droplet-Lung-nan-21m-Lymphocytic-Zbtb32+_B\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 LIPC FCRL1 SPIB CMAHP	4.67e-06	176	62	5	741fdacb33d49b030a797a6099fdea0949a22e75
ToppCell	droplet-Lung-nan-21m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 LIPC FCRL1 SPIB CMAHP	5.22e-06	180	62	5	b673d11d764e275883fc5edbad97137a6549df6a
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH CFHR1 NID2 PCDHGB7 NEXN	5.36e-06	181	62	5	c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNB AOX1 LAMB2 TMEM255B ADGRG6	5.36e-06	181	62	5	136b0c60680068838d184d32aa99d7bea8718dbc
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MKRN3 FLNB PCDHGB7 TMEM255B ADGRG6	5.36e-06	181	62	5	4ea02344e1996f264dd5e14f3b19c8782ce41699
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH CFHR1 NID2 PCDHGB7 NEXN	5.36e-06	181	62	5	c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 RELN CNTNAP4 CSMD3 RYR2	5.80e-06	184	62	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 RELN CNTNAP4 CSMD3 RYR2	5.80e-06	184	62	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 RELN CNTNAP4 CSMD3 RYR2	5.80e-06	184	62	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-Zbtb32+_B_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FRAS1 LIPC FCRL1 SPIB CMAHP	5.96e-06	185	62	5	5fd4a3776259c96cf2dcb87f050af8226acbbda9
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FRAS1 LIPC FCRL1 SPIB CMAHP	5.96e-06	185	62	5	4c55fa96877ab9a00fcbec3fb70fd2208d222527
ToppCell	15-Trachea-Epithelial-Secretory_progenitor\|Trachea / Age, Tissue, Lineage and Cell class	CFH CFHR1 SLC41A2 KLHL24 LAMB2	6.28e-06	187	62	5	be9fce9e74b2f170a2067f1b31d802912a578329
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPEG PDGFC NEXN RYR2 ADGRG6	6.44e-06	188	62	5	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GALT1 SPEG LAMB2 CSMD3 NEXN	6.44e-06	188	62	5	d1a4cd4db95d8d32b79156290f7867f32824cc87
ToppCell	droplet-Lung-nan-18m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB LAMA5 LAMB2 TMEM255B ADGRG6	6.44e-06	188	62	5	405efea75233ecf70f7d19b630230798d817b7f2
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPEG LAMA5 TMEM255B NEXN RYR2	6.44e-06	188	62	5	a5e7a363fbd5ae4d9312cf6f9941413d6a5c0b4d
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 MAOA AOX1 RORA SLC16A12	6.61e-06	189	62	5	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	pdx-Tumor_cells-T8\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	SEC16B LIPC MAOB PTGR1 PPARA	6.78e-06	190	62	5	b05db0de9b6ae01dd30074453f7de44f7397631e
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NID2 RELN PLA1A LAMB2 SLC16A12	6.78e-06	190	62	5	f50b9814a1beac67dc042a8c27dfd085ceeda3a6
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NID2 RELN PLA1A LAMB2 SLC16A12	6.78e-06	190	62	5	a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	CFH MAOB AOX1 RORA RYR2	6.78e-06	190	62	5	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NID2 RELN PLA1A LAMB2 SLC16A12	6.78e-06	190	62	5	57c136bf6d7feafb4a220877bed0cc8fdf314db2
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG LAMA5 NEXN RYR2 ADGRG6	6.96e-06	191	62	5	8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPEG PDGFC NEXN RYR2 ADGRG6	6.96e-06	191	62	5	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLHL24 RELN LIPC PSME4 SPIB	7.50e-06	194	62	5	11709704079f24a730476572dc2f01e9d2226e2c
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLHL24 RELN LIPC PSME4 SPIB	7.50e-06	194	62	5	3a1f95639d5f239f001bd67d4213e8938e7f299d
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NID2 MAOA RORA CSMD3 NEXN	7.50e-06	194	62	5	99577a5a631e607b5abe7a1b0d8d6a5eabe50196
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH NID2 RELN CR1 ADGRG6	7.50e-06	194	62	5	43eb677a76634bb9a48a40e0d607c4936ae64bcc
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFH MAOB AOX1 RORA RYR2	7.89e-06	196	62	5	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH NID2 RELN CR1 ADGRG6	7.89e-06	196	62	5	545d2e4469924d333e3f655f559c899fa1260196
ToppCell	368C-Fibroblasts-Fibroblast-G\|368C / Donor, Lineage, Cell class and subclass (all cells)	CFH FRAS1 MAOA MAOB NEXN	8.08e-06	197	62	5	156155c2f0c1a2461e45803da578af18ee221660
ToppCell	AT1_cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	FLNB LIPC LAMA5 LAMB2 NEXN	8.08e-06	197	62	5	80d81be244c94c435accb643449b4ce6a3462c7f
ToppCell	368C-Fibroblasts-Fibroblast-G-\|368C / Donor, Lineage, Cell class and subclass (all cells)	CFH FRAS1 MAOA MAOB NEXN	8.08e-06	197	62	5	d5d9263451f6c10cb3b9c17740183ca334e24851
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLCO5A1 SLC41A2 SPIB ALDH2 FAM118A	8.28e-06	198	62	5	c58e2d3a21fcca9f1accccc5303ca4222b6c8432
ToppCell	Epithelial_cells-Epithelial_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	MAOA MAOB PTGR1 AOX1 SLC16A12	8.28e-06	198	62	5	52e9d41a1726bc1140df6baec9f17a534448ac8b
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLCO5A1 SLC41A2 SPIB ALDH2 FAM118A	8.28e-06	198	62	5	f4ff9520598ebc52b3a1f31eee766957983e16b4
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFH MAOB AOX1 NEXN RYR2	8.28e-06	198	62	5	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	Epithelial_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	MAOA MAOB PTGR1 AOX1 SLC16A12	8.28e-06	198	62	5	eeec789d226171f30799577cc37c07bdced2e3cb
ToppCell	BAL-Severe-Myeloid-cDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SLCO5A1 SLC41A2 SPIB ALDH2 FAM118A	8.49e-06	199	62	5	0b20ae65b9340d844e271acda9e116d98fc1cc69
ToppCell	BAL-Severe-Myeloid-cDC-cDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SLCO5A1 SLC41A2 SPIB ALDH2 FAM118A	8.49e-06	199	62	5	bb9e7418468b88cdfaa78788d062362794ea8230
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Mesothelial-2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	NID2 FRAS1 AOX1 NEXN SLC16A12	8.49e-06	199	62	5	60a653100aff31f7f96796ff2ec634798bfb4b0d
ToppCell	BAL-Severe-Myeloid-cDC-cDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SLCO5A1 SLC41A2 SPIB ALDH2 FAM118A	8.49e-06	199	62	5	9a0e853693e572c63b135f937b2cffd4dd4026fb
ToppCell	Severe_COVID-19-Myeloid-cDC\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	SLCO5A1 SLC41A2 SPIB ALDH2 FAM118A	8.49e-06	199	62	5	9132c1929d3445fcca49f76f010ca37adeb70315
ToppCell	BAL-Severe-Myeloid-cDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SLCO5A1 SLC41A2 SPIB ALDH2 FAM118A	8.49e-06	199	62	5	d017848256704ae7237030868b143c3f0842a9c3
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CFH FRAS1 MAOB NEXN RYR2	8.70e-06	200	62	5	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	CFH NID2 FRAS1 AOX1 NEXN	8.70e-06	200	62	5	c082bc21ec7c5323439d108ea8aea510e1113c3f
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CFH FRAS1 MAOB NEXN RYR2	8.70e-06	200	62	5	a510deaada669e690329183e18df02870bd204b3
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	MAOB LAMB2 PDGFC NEXN ADGRG6	8.70e-06	200	62	5	593bf6a7c557437db9a9249a5058a46014179ef6
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	NID2 MAOB AOX1 NEXN RYR2	8.70e-06	200	62	5	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CFH FRAS1 MAOB NEXN RYR2	8.70e-06	200	62	5	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RELN CNTNAP4 OR4D6 CSMD3	3.07e-05	128	62	4	91072ca56bce2c552a95edd67e17f43d8cc1de95
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	RELN CNTNAP4 CSMD3 RYR2	5.13e-05	146	62	4	c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH NID2 MAOB ADGRG6	5.55e-05	149	62	4	cc6224c6b79f43b97adc1ce48ca4906bff2ad318
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH NID2 MAOB ADGRG6	5.55e-05	149	62	4	24a7538b54b2a5291503c7493fefed4e45e8d710
ToppCell	Lymphoid-Lymphoid-B_cells\|Lymphoid / shred on cell class and cell subclass (v4)	FCRL1 SPIB ALDH2 CMAHP	5.70e-05	150	62	4	5ebf6b4b9b029422a4676ba09a6a9225bd25db47
ToppCell	droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH CFHR1 CFHR2 MAOB	5.85e-05	151	62	4	cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4
ToppCell	Club-club-1\|World / Class top	NEXN SEC14L4 ADGRG6	5.88e-05	54	62	3	48f80b20b1c4995a0f7084d31666781dce4009a9
ToppCell	Adult-Epithelial-basal_cell-D122\|Adult / Lineage, Cell type, age group and donor	CFH FRAS1 SLC16A12 ADGRG6	6.31e-05	154	62	4	38d346402417960044ae999e61f0092b46f2b591
ToppCell	primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CFH PLA1A LAMB2 SLC16A12	6.47e-05	155	62	4	ced64e26962c5c6e6d539f361fe57ab0b399e999
ToppCell	primary_visual_cortex-Non-neuronal-pericyte_cell\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CFH PLA1A LAMB2 SLC16A12	6.47e-05	155	62	4	0f24ef6486aef354f0911c06932cb01d1a0525ac
ToppCell	primary_visual_cortex-Non-neuronal-pericyte_cell-Peri\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CFH PLA1A LAMB2 SLC16A12	6.47e-05	155	62	4	d8b5145258f075b15080f8739f537f48dd22225e
ToppCell	facs-Liver-Hepatocytes\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFHR1 SEC16B LIPC PLA1A	6.63e-05	156	62	4	e2cda3ad4e5f44a80133864c5a38b766afb952ce
ToppCell	Children_(3_yrs)-Epithelial-basal_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CFH FRAS1 LAMA5 SLC16A12	6.97e-05	158	62	4	d78e7e52657dc094430291fec07e9c298be9e584
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	NID2 AOX1 PPARA SLC16A12	7.14e-05	159	62	4	92049a8d8fc9997d8d0d76500c72596a9b2394e0
ToppCell	ICU-SEP-Myeloid-cDC1\|ICU-SEP / Disease, Lineage and Cell Type	CFHR1 SLC41A2 PLA1A LAMA5	7.50e-05	161	62	4	9fb73909fc2ec99f96ca2eed1a053bce89de7d16
ToppCell	droplet-Fat-Scat-21m-Lymphocytic-B_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIPC FCRL1 SPIB CMAHP	7.50e-05	161	62	4	e52735f955f0a53da5cbe5a2d77a00484e5109b3
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFHR2 PTGR1 PDGFC ADGRG6	7.68e-05	162	62	4	3a1cbfed5a063131d49e3c1584f62b12660ecb36
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFHR2 PTGR1 PDGFC ADGRG6	7.68e-05	162	62	4	04b3c38bb27fa369a9ac5b60883f8b058abc5180
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	RELN CNTNAP4 CSMD3 RYR2	7.86e-05	163	62	4	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	343B-Myeloid-Dendritic-cDC_activated\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	SLCO5A1 SLC41A2 SPIB FAM118A	8.05e-05	164	62	4	eae6d440877b292ad18dc4bd02802dda5b2f9c60
ToppCell	facs-Heart-RA-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIPC FCRL1 SPIB CMAHP	8.44e-05	166	62	4	fc2cf67311c86fda75b35fcd4768b6f6f14c59d0
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH FCRL1 PCDHGB7 PTGR1	8.44e-05	166	62	4	7495961adcefe5c1fb288913b1a5236328a04703
ToppCell	facs-Heart-RA-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIPC FCRL1 SPIB CMAHP	8.44e-05	166	62	4	33a6876d06e26176135a73a77c19e634ec53f7ce
ToppCell	356C-Myeloid-Dendritic-cDC_activated\|356C / Donor, Lineage, Cell class and subclass (all cells)	SLCO5A1 SPIB PLA1A FAM118A	8.64e-05	167	62	4	43a9375fdbafd7450c553e4620e21537e08639dd
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-CD45____B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIPC FCRL1 SPIB CMAHP	9.04e-05	169	62	4	d44fc49056799dfc70a3c7d538c210d88ffded05
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_11\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SLCO5A1 SLC41A2 FLNB ADGRG6	9.04e-05	169	62	4	e3410ccb3f85811c75694e286115803911169a2f
ToppCell	343B-Myeloid-Dendritic-cDC_activated\|343B / Donor, Lineage, Cell class and subclass (all cells)	SLCO5A1 SLC41A2 SPIB FAM118A	9.04e-05	169	62	4	2098f15a388d019ed7f1d4c209affd5ca2886dcc
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_11\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SLCO5A1 SLC41A2 FLNB ADGRG6	9.04e-05	169	62	4	a4f610d07c3ba5537f4497f523669b914f7eddc1
ToppCell	356C-Myeloid-Dendritic-cDC_activated\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	SLCO5A1 SPIB LAMA5 FAM118A	9.04e-05	169	62	4	44d201361eb497222a4972a0e10bac1e05dcfd0a
ToppCell	droplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN LIPC FCRL1 SPIB	9.25e-05	170	62	4	29deb285d5a82c0abcc108012ca42f4b4b4d9e19
ToppCell	droplet-Thymus-nan-21m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN LIPC FCRL1 SPIB	9.25e-05	170	62	4	dc35d66a9a9fe6cdd7f4ec0fe7efa49d02f2b5b2
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LIPC FCRL1 SPIB CMAHP	9.25e-05	170	62	4	53fd50c9a27d47662fbcbd7e9e9837f72ac448c5
Computational	Oxidoreductases.	MAOA MAOB AOX1 GOT2	1.15e-06	22	40	4	MODULE_373
Computational	DRG (dorsal root ganglia) genes.	CFH CFHR1 MAOA MAOB LAMA5 LAMB2 ADGRG6	4.73e-04	384	40	7	MODULE_2
Computational	Genes in the cancer module 557.	MAOA MAOB	7.27e-04	11	40	2	MODULE_557
Computational	Genes upregulated in subsets of cells of a given type within various tumors	FLNB PLA1A CMAHP	7.35e-04	48	40	3	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PI16_POS
Computational	Trachea genes.	CFH CFHR1 MAOA LAMA5 LAMB2 CMAHP ADGRG6	7.51e-04	415	40	7	MODULE_6
Drug	methylimidazole acetaldehyde	MAOA MAOB AOX1 ALDH2	1.16e-07	17	62	4	CID000193545
Drug	isovanillin	MAOA MAOB AOX1 ALDH2	1.48e-07	18	62	4	CID000012127
Drug	5-HIAL	MAOA MAOB AOX1 ALDH2	1.87e-07	19	62	4	CID000074688
Drug	tristearin	CFHR2 LIPC GK2 PNLIPRP2 PLA1A LAMA5 PPARA GOT2	8.31e-07	277	62	8	CID000011146
Drug	indole-3-acetaldehyde	MAOA MAOB AOX1 ALDH2	9.72e-07	28	62	4	CID000000800
Drug	LMWH	CFH CFHR1 CFHR2 NID2 LIPC PNLIPRP2 CSNK1G1 LAMA5 LAMB2 CFHR5 RYR2	1.55e-06	663	62	11	CID000000772
Drug	RS-8359	MAOA MAOB AOX1	1.60e-06	9	62	3	CID000164116
Drug	CPD 30	MAOA MAOB ALDH2	1.60e-06	9	62	3	CID000440850
Drug	I 1100	MAOA MAOB	7.30e-06	2	62	2	CID000013067
Drug	5HAA	MAOA MAOB	7.30e-06	2	62	2	CID000128291
Drug	trimethyl citrate	MAOA MAOB	7.30e-06	2	62	2	CID000074112
Drug	Pargyline	MAOA MAOB	7.30e-06	2	62	2	DB01626
Drug	tribulin	MAOA MAOB	7.30e-06	2	62	2	ctd:C039776
Drug	methyl indole-3-propionate	MAOA MAOB	7.30e-06	2	62	2	CID000021711
Drug	3-methoxymethyl-7-(4,4,4-trifluorobutoxy)-3,3a,4,5-tetrahydro-1,3-oxazolo(3,4-a)quinolin-1-one	MAOA MAOB	7.30e-06	2	62	2	ctd:C492672
Drug	Isocarboxazid	MAOA MAOB	7.30e-06	2	62	2	DB01247
Drug	2-chloroquinoxaline	MAOA MAOB	7.30e-06	2	62	2	CID000238938
Drug	NSC310407	MAOA MAOB	7.30e-06	2	62	2	CID000171344
Drug	Selegiline	MAOA MAOB	7.30e-06	2	62	2	DB01037
Drug	C05636	MAOA MAOB	7.30e-06	2	62	2	CID000440736
Drug	4,8-quinolinediol	MAOA MAOB	7.30e-06	2	62	2	CID000440737
Drug	1 mm PP	MAOA MAOB	7.30e-06	2	62	2	CID000132866
Drug	Tranylcypromine	MAOA MAOB	7.30e-06	2	62	2	DB00752
Drug	ethyl 4-hydroxyphenylacetate	MAOA MAOB	7.30e-06	2	62	2	CID000028310
Drug	AC1L2OJZ	MAOA MAOB	7.30e-06	2	62	2	CID000125421
Drug	glycerol	LIPC GK2 GLA MAOA PNLIPRP2 PLA1A AOX1 LAMB2 PPARA ALDH2 GOT2	1.30e-05	829	62	11	CID000000753
Drug	Aminopurine, 6-benzyl [1214-39-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A	KLHL24 GK2 MAOA SPIB RORA PDGFC	1.64e-05	198	62	6	2313_UP
Drug	homoveratric acid	MAOB AOX1	2.18e-05	3	62	2	CID000007139
Drug	esuprone	MAOA MAOB	2.18e-05	3	62	2	CID000065827
Drug	Monomethylhydrazine	MAOA MAOB	2.18e-05	3	62	2	ctd:D009002
Drug	Zimelidine	MAOA MAOB	2.18e-05	3	62	2	DB04832
Drug	Nialamide	MAOA MAOB	2.18e-05	3	62	2	DB04820
Drug	indoleacetaldehyde	MAOA MAOB	2.18e-05	3	62	2	ctd:C001655
Drug	4,6-quinolinediol	MAOA MAOB	2.18e-05	3	62	2	CID000440738
Drug	tributyrin	LIPC PNLIPRP2 PLA1A LAMB2	2.80e-05	64	62	4	CID000006050
Drug	coprine	MAOA MAOB ALDH2	2.85e-05	22	62	3	CID000108079
Drug	spizofurone	MAOA MAOB	4.36e-05	4	62	2	CID000071755
Drug	N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine	MAOA MAOB	4.36e-05	4	62	2	ctd:C570530
Drug	AC1NOLIN	MAOA MAOB	4.36e-05	4	62	2	CID005090283
Drug	Ketones	PTGR1 PPARA	4.36e-05	4	62	2	ctd:D007659
Drug	1,4-diphenyl-2-butene	MAOA MAOB	4.36e-05	4	62	2	CID005287453
Drug	Vitamin B 12	MAOB PPARA ALDH2	4.78e-05	26	62	3	ctd:D014805
Drug	chlorphentermine	MAOA MAOB PLA1A	4.78e-05	26	62	3	CID000010007
Drug	phenyloxazolidinone	MAOA MAOB	7.26e-05	5	62	2	CID000136547
Drug	Phentermine	MAOA MAOB	7.26e-05	5	62	2	DB00191
Drug	RS-45041-190	MAOA MAOB	7.26e-05	5	62	2	CID000127951
Drug	GLA-27	RELN GLA	7.26e-05	5	62	2	CID000163574
Drug	Nomifensine	MAOA MAOB	7.26e-05	5	62	2	DB04821
Drug	Furazolidone-d4	MAOA MAOB ALDH2	7.41e-05	30	62	3	CID000003435
Drug	3,4-dihydroxyphenylacetaldehyde	MAOA MAOB ALDH2	7.41e-05	30	62	3	CID000119219
Drug	hexadecanedioic acid	LIPC PPARA GOT2	9.90e-05	33	62	3	CID000010459
Drug	TAPB	CFH FLNB	1.09e-04	6	62	2	CID000130770
Drug	Pargyline	MAOA MAOB	1.09e-04	6	62	2	ctd:D010293
Drug	MeIAA	MAOA MAOB	1.09e-04	6	62	2	CID000074706
Drug	4-hydroxy-3-methoxymandelaldehyde	MAOA MAOB	1.09e-04	6	62	2	CID000440729
Drug	Phosphamidon	MAOA MAOB	1.09e-04	6	62	2	ctd:D010707
Drug	Phenethylamines	MAOA MAOB	1.09e-04	6	62	2	ctd:D010627
Drug	MDAI	MAOA MAOB	1.09e-04	6	62	2	CID000125558
Drug	Factor Xiiib	CFH CFHR2 CFHR5	1.18e-04	35	62	3	CID000126166
Drug	Creosote	MAOA MAOB ALDH2	1.52e-04	38	62	3	ctd:D003407
Drug	N-propargylbenzylamine	MAOB ALDH2	1.52e-04	7	62	2	CID000099277
Drug	BU 224	MAOA MAOB	1.52e-04	7	62	2	CID000002457
Drug	N-(2-aminoethyl)benzamide	MAOA MAOB	1.52e-04	7	62	2	CID000423156
Drug	cimoxatone	MAOA MAOB	1.52e-04	7	62	2	CID000052542
Drug	iproclozide	MAOA MAOB	1.52e-04	7	62	2	CID000019063
Drug	p-dimethylaminocinnamaldehyde	GLA AOX1	1.52e-04	7	62	2	CID000092224
Drug	MMDA	MAOA MAOB	1.52e-04	7	62	2	DB01442
Drug	4-Methoxyamphetamine	MAOA MAOB	1.52e-04	7	62	2	DB01472
Drug	gentisaldehyde	AOX1 ALDH2	1.52e-04	7	62	2	CID000070949
Drug	4-methoxytranylcypromine	MAOA MAOB	1.52e-04	7	62	2	CID003082143
Drug	AC1Q7A1G	MAOA MAOB	1.52e-04	7	62	2	CID000002665
Drug	JB 835	MAOA MAOB	1.52e-04	7	62	2	CID000152988
Drug	1-benzylcyclopropylamine	MAOA MAOB	1.52e-04	7	62	2	CID000152923
Drug	5-hydroxykynurenamine	MAOA MAOB	1.52e-04	7	62	2	CID000164719
Drug	SR 95191	MAOA MAOB	1.52e-04	7	62	2	CID000072119
Drug	salsolidine	MAOA MAOB	1.52e-04	7	62	2	CID000010302
Drug	Phenelzine	MAOA MAOB	1.52e-04	7	62	2	DB00780
Drug	MPTP-3-ol	MAOA MAOB	1.52e-04	7	62	2	CID000100194
Drug	phenylacetaldehyde	MAOA MAOB AOX1 ALDH2	1.61e-04	100	62	4	CID000000998
Drug	BCMTD	LIPC PPARA GOT2	1.64e-04	39	62	3	CID000161757
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A	KLHL24 MAOA MAOB LAMA5 LAMB2	1.82e-04	193	62	5	1647_UP
Drug	Flecainide acetate [54143-56-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A	GK2 PSME4 MAOB SPEG PPARA	1.91e-04	195	62	5	3843_UP
Drug	nifedipine; Up 200; 10uM; MCF7; HG-U133A	NID2 FRAS1 SPEG CDADC1 RORA	2.00e-04	197	62	5	335_UP
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A	KLHL24 RELN PSME4 MAOB CR1	2.00e-04	197	62	5	3622_DN
Drug	monoperphthalic acid	MAOA ALDH2	2.02e-04	8	62	2	CID000075329
Drug	AC1O5VTH	MAOA MAOB	2.02e-04	8	62	2	CID006441710
Drug	pralidoxime	MAOA MAOB	2.02e-04	8	62	2	ctd:C028797
Drug	ethylphenyl(2-formylethyl)phosphinate	AOX1 ALDH2	2.02e-04	8	62	2	CID000151185
Drug	Thiophanate	AOX1 PPARA	2.02e-04	8	62	2	ctd:D013875
Drug	3,4-dimethylcoumarin	MAOA GOT2	2.02e-04	8	62	2	CID000599941
Drug	mofegiline	MAOA MAOB	2.02e-04	8	62	2	CID006437850
Drug	pyrazidol	MAOA MAOB	2.02e-04	8	62	2	CID000068802
Drug	4-fluorotranylcypromine	MAOA MAOB	2.02e-04	8	62	2	CID003082666
Drug	homovanillin	MAOA MAOB	2.02e-04	8	62	2	CID000151276
Drug	benzyl benzoate	MAOA MAOB	2.02e-04	8	62	2	ctd:C006723
Drug	4-quinolone	MAOA MAOB	2.02e-04	8	62	2	CID000069141
Drug	Paroxetine maleate [64006-44-6]; Up 200; 1uM; MCF7; HT_HG-U133A	KLHL24 SPIB SPEG CDADC1 RORA	2.05e-04	198	62	5	3904_UP
Drug	Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A	MKRN3 ORC5 SPEG ALDH2 RYR2	2.10e-04	199	62	5	5048_UP
Drug	Rilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A	MKRN3 AOX1 RORA PPARA ALDH2	2.14e-04	200	62	5	5532_UP
Drug	3,4,3',4'-tetrachlorobiphenyl	CFHR1 KLHL24 PSME4 MAOB PPARA SEC14L4 SLC16A12	2.25e-04	453	62	7	ctd:C028451
Disease	C3 glomerulopathy	CFH CFHR1 CFHR2 CFHR5	2.07e-09	9	61	4	C4087273
Disease	Complement deficiency disease	CFH CFHR1 CFHR2 CFHR5	6.47e-07	33	61	4	C0272242
Disease	hemopexin measurement	CFH CFHR1 CFHR5	1.37e-06	11	61	3	EFO_0008149
Disease	complement factor H-related protein 5 measurement	CFH CFHR1 CFHR2 CFHR5	1.74e-06	42	61	4	EFO_0008098
Disease	complement factor H-related protein 4 measurement	CFH CFHR1 CFHR2 CFHR5	3.27e-06	49	61	4	EFO_0600091
Disease	CFHR5 DEFICIENCY	CFHR1 CFHR5	4.20e-06	2	61	2	C3553720
Disease	Huntington Disease	RELN MAOA MAOB	5.60e-06	17	61	3	C0020179
Disease	complement factor H-related protein 1 measurement	CFH CFHR1 CFHR2 CFHR5	5.60e-06	56	61	4	EFO_0600054
Disease	atrophic macular degeneration, age-related macular degeneration, wet macular degeneration	CFH CFHR1 LIPC CFHR5	7.39e-06	60	61	4	EFO_0001365, EFO_0004683, EFO_1001492
Disease	Alzheimer's disease (is_implicated_in)	LIPC MAOA MAOB PPARA ALDH2	8.08e-06	132	61	5	DOID:10652 (is_implicated_in)
Disease	tyrosine-protein kinase transmembrane receptor ROR2 measurement	CFH RORA	1.26e-05	3	61	2	EFO_0803209
Disease	anaphase-promoting complex subunit 7 measurement	CFH CFHR1	1.26e-05	3	61	2	EFO_0801381
Disease	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1	CFH CFHR1	1.26e-05	3	61	2	C2749604
Disease	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1	CFH CFHR1	1.26e-05	3	61	2	235400
Disease	calnexin measurement	CFH CFHR1	1.26e-05	3	61	2	EFO_0801444
Disease	complement factor H-related protein 4A measurement	CFH CFHR1	1.26e-05	3	61	2	EFO_0600057
Disease	Hemolytic uremic syndrome, atypical, susceptibility to, 1	CFH CFHR1	1.26e-05	3	61	2	cv:C2749604
Disease	histone-lysine N-methyltransferase 2D measurement	CFH CFHR1	1.26e-05	3	61	2	EFO_0801683
Disease	Fc receptor-like protein 5 measurement	CFH PCIF1	1.26e-05	3	61	2	EFO_0802545
Disease	skin pigmentation	CFHR2 RORA CFHR5 TMEM255B	1.29e-05	69	61	4	EFO_0003784
Disease	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement	CFH CFHR1	2.52e-05	4	61	2	EFO_0803292
Disease	kallikrein-5 measurement	CFH CFHR1	2.52e-05	4	61	2	EFO_0020515
Disease	complement factor H-related protein 2 measurement	CFH CFHR1 CFHR2	2.96e-05	29	61	3	EFO_0600055
Disease	Age related macular degeneration	CFH CFHR1 CFHR2	3.28e-05	30	61	3	C0242383
Disease	C-C motif chemokine 27 measurement	CFH PPARA	4.19e-05	5	61	2	EFO_0020198
Disease	brain infarction (is_implicated_in)	CFH ALDH2	4.19e-05	5	61	2	DOID:3454 (is_implicated_in)
Disease	Hyperlipoproteinemias	LIPC PPARA	4.19e-05	5	61	2	C0020476
Disease	Membranoproliferative Glomerulonephritis, Type II	CFH CFHR1	6.27e-05	6	61	2	C0268743
Disease	complement C1s subcomponent measurement	CFH CFHR1	6.27e-05	6	61	2	EFO_0008091
Disease	complement factor H measurement	CFH CFHR1 CFHR2	8.47e-05	41	61	3	EFO_0008097
Disease	atypical hemolytic-uremic syndrome (is_implicated_in)	CFH CFHR1	1.17e-04	8	61	2	DOID:0080301 (is_implicated_in)
Disease	puberty onset measurement	SEC16B PTGR1 RORA FAM118A	1.33e-04	125	61	4	EFO_0005677
Disease	angina pectoris	CFH PCNX3 ALDH2 CMAHP	1.33e-04	125	61	4	EFO_0003913
Disease	Atypical hemolytic-uremic syndrome	CFH CFHR1	1.50e-04	9	61	2	cv:C2931788
Disease	chronic central serous retinopathy	CFH RORA	1.50e-04	9	61	2	EFO_0009363
Disease	Hemolytic-uremic syndrome	CFH CFHR1	1.50e-04	9	61	2	cv:C0019061
Disease	leukocyte immunoglobulin-like receptor subfamily A member 5 measurement	CFH CFHR1	1.50e-04	9	61	2	EFO_0801766
Disease	Atypical Hemolytic Uremic Syndrome	CFH CFHR1	1.87e-04	10	61	2	C2931788
Disease	f-box/LRR-repeat protein 4 measurement	CFH PCIF1	1.87e-04	10	61	2	EFO_0802538
Disease	Autistic Disorder	RELN MAOA MAOB RORA CSMD3	2.07e-04	261	61	5	C0004352
Disease	Huntington Disease, Late Onset	MAOA MAOB	2.74e-04	12	61	2	C0393574
Disease	Akinetic-Rigid Variant of Huntington Disease	MAOA MAOB	2.74e-04	12	61	2	C0751207
Disease	Juvenile Huntington Disease	MAOA MAOB	2.74e-04	12	61	2	C0751208
Disease	salicylurate measurement	B3GALT1 RYR2	3.23e-04	13	61	2	EFO_0010532
Disease	Fulminant Hepatic Failure with Cerebral Edema	MAOA MAOB	3.23e-04	13	61	2	C0751197
Disease	Hepatic Stupor	MAOA MAOB	3.23e-04	13	61	2	C0751198
Disease	FVC change measurement, response to placebo	ORC5 RELN	3.23e-04	13	61	2	EFO_0008344, EFO_0010339
Disease	Hepatic Encephalopathy	MAOA MAOB	3.23e-04	13	61	2	C0019151
Disease	Hepatic Coma	MAOA MAOB	3.23e-04	13	61	2	C0019147
Disease	schizophrenia (implicated_via_orthology)	RELN PPARA CSMD3	3.83e-04	68	61	3	DOID:5419 (implicated_via_orthology)
Disease	age-related macular degeneration, COVID-19	CFH CFHR1 LIPC	4.00e-04	69	61	3	EFO_0001365, MONDO_0100096
Disease	complement factor H-related protein 3 measurement	CFH CFHR1 CFHR2 CFHR5	4.20e-04	169	61	4	EFO_0600056
Disease	tumor necrosis factor measurement	CFH LIPC	4.34e-04	15	61	2	EFO_0010834
Disease	triglycerides to total lipids in chylomicrons and extremely large VLDL percentage	LIPC PCIF1	4.34e-04	15	61	2	EFO_0022328
Disease	alcohol use disorder (is_implicated_in)	MAOA ALDH2	4.95e-04	16	61	2	DOID:1574 (is_implicated_in)
Disease	Pheochromocytoma, Extra-Adrenal	MAOA MAOB	4.95e-04	16	61	2	C1257877
Disease	aspartate aminotransferase measurement	CFH FLNB LIPC RORA ALDH2 FAM118A CMAHP GOT2	5.27e-04	904	61	8	EFO_0004736
Disease	Lipidemias	LIPC PPARA	5.60e-04	17	61	2	C1706412
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	LIPC PCIF1	5.60e-04	17	61	2	EFO_0022232
Disease	Hyperlipidemia	LIPC PPARA	5.60e-04	17	61	2	C0020473
Disease	Age-related macular degeneration	CFH CFHR1	6.30e-04	18	61	2	cv:C0242383
Disease	esterified cholesterol measurement, high density lipoprotein cholesterol measurement	LIPC PCIF1	7.03e-04	19	61	2	EFO_0004612, EFO_0008589
Disease	Pheochromocytoma	MAOA MAOB	7.03e-04	19	61	2	C0031511
Disease	serum iron measurement	GK2 RORA CMAHP	7.61e-04	86	61	3	EFO_0006332
Disease	sucrose liking measurement	ORC5 RELN	7.80e-04	20	61	2	EFO_0010157
Disease	coagulation factor measurement	CFH CFHR5	7.80e-04	20	61	2	EFO_0004634
Disease	descending aortic diameter	CFH FLNB ALDH2	8.14e-04	88	61	3	EFO_0021788
Disease	age-related macular degeneration	CFH CFHR1 CFHR5	8.41e-04	89	61	3	EFO_0001365
Disease	free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	LIPC PCIF1	8.61e-04	21	61	2	EFO_0022277
Disease	cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage	LIPC PCIF1	8.61e-04	21	61	2	EFO_0022246
Disease	Nephritis, Tubulointerstitial	GLA SLC16A12	8.61e-04	21	61	2	C0041349
Disease	Kidney Failure	GLA CFHR5	9.46e-04	22	61	2	C0035078
Disease	body weight	NID2 SEC16B KLHL24 RELN LIPC CNTNAP4 RORA ELP3 ADGRG6	1.08e-03	1261	61	9	EFO_0004338
Disease	Nephritis, Interstitial	GLA SLC16A12	1.13e-03	24	61	2	C0027707
Disease	Acute Confusional Senile Dementia	RELN MAOB CR1	1.14e-03	99	61	3	C0546126
Disease	Alzheimer's Disease, Focal Onset	RELN MAOB CR1	1.14e-03	99	61	3	C0750900
Disease	Alzheimer Disease, Early Onset	RELN MAOB CR1	1.14e-03	99	61	3	C0750901
Disease	Presenile dementia	RELN MAOB CR1	1.14e-03	99	61	3	C0011265
Disease	Alzheimer Disease, Late Onset	RELN MAOB CR1	1.14e-03	99	61	3	C0494463
Disease	Familial Alzheimer Disease (FAD)	RELN MAOB CR1	1.18e-03	100	61	3	C0276496
Disease	Alzheimer's Disease	RELN MAOB CR1	1.21e-03	101	61	3	C0002395
Disease	cholesterol to total lipids in small LDL percentage	LIPC PCIF1	1.43e-03	27	61	2	EFO_0022241
Disease	cholesterol to total lipids in medium LDL percentage	LIPC PCIF1	1.43e-03	27	61	2	EFO_0022238
Disease	Myopathy	MAOA PPARA	1.76e-03	30	61	2	C0026848
Disease	cholesterol to total lipids in very large HDL percentage	LIPC PCIF1	1.88e-03	31	61	2	EFO_0022243
Disease	Mental Depression	RELN MAOA MAOB RORA	1.90e-03	254	61	4	C0011570

Protein segments in the cluster

Peptide	Gene	Start	Entry
GNFTYGTVVFYDCNP	CSMD3	2951	Q7Z407
QDPVIFYVTCAGYFG	ADGRG6	1016	Q86SQ4
NYPPFCSGTGYIFSA	B3GALT1	231	Q9Y5Z6
YTGPFCSNEISAYFG	CNTNAP4	991	Q9C0A0
TCAGFPGSFGYYDID	GLA	141	P06280
SPPYYYGDSVEFNCS	CFH	706	P08603
FVGCGYNAFPVGSEY	CDADC1	361	Q9BWV3
GQPFEYFVYGAACSE	AOX1	1156	Q06278
TYCLYLPETFPEDGG	NEXN	636	Q0ZGT2
GTLPYAYNFCVPGDQ	PCDHGB7	746	Q9Y5F8
SDEYFPSEPGFCIHY	PDGFC	146	Q9NRA1
QYSGGCYTAYFPPGI	MAOA	401	P21397
EQYSGGCYTTYFPPG	MAOB	391	P27338
STPLYFPYNQCSYEG	MSANTD1	166	Q6ZTZ1
ICLATFPYVYGFSDG	OR5M11	141	Q96RB7
YLCTGKDGYVPFFDP	FRAS1	3721	Q86XX4
EVGTSYGCYFVPAFS	GK3P	351	Q14409
YGCYFVPAFSGLYAP	GK3P	356	Q14409
SAGEGLPQVYYFGPC	CSNK1G1	96	Q9HCP0
GSCSAEYIPFAPGDY	FLNB	1381	O75369
GNYGPGDCFVLASDY	PCNX3	1366	Q9H6A9
PFSQVPTGEVFYYSC	CFHR2	41	P36980
TYFYPCPCGDNFSIT	DPH3	21	Q96FX2
GCQEYTGAPYFAAIS	NAXD	81	Q8IW45
YDFYPNGGSFQPGCH	LIPC	241	P11150
RYFSYDCGADFPGVP	LAMB2	176	P55268
IPNGPFSFYGDYQSE	LHX1	271	P48742
VPGAYNFPYCEAGSC	LAMA5	711	O15230
PDDFVFYVGGYPSTF	LAMA5	2871	O15230
FPFCGPNTLDAFYCY	OR4D6	166	Q8NGJ1
FGLDGVYISEPCPSY	RELN	1401	P78509
GYYGDGFQCIPDSTS	NID2	921	Q14112
VSYGDCFDHFPGYVQ	FAM118A	286	Q9NWS6
GFNLPYTECYDPVTG	KLHL24	326	Q6TFL4
RQYCSAFPDTDGYFG	PCIF1	521	Q9H4Z3
EVGTSYGCYFVPAFS	GK2	351	Q14410
YGCYFVPAFSGLYAP	GK2	356	Q14410
FSPGQEVFYSCEPGY	CR1	316	P17927
FSPGQEVFYSCEPGY	CR1	766	P17927
FSPGQEVFYSCEPGY	CR1	1216	P17927
YYCVAENGYGPSPSG	FCRL1	181	Q96LA6
PFSQVPTGEVFYYSC	CFHR5	41	Q9BXR6
YCPGGPDSDFEYSTQ	ELP3	111	Q9H9T3
NPVYYGPSDFFIGAV	EFHC1	481	Q5JVL4
CCGSYFPGYPIYGTN	KRTAP7-1	6	Q8IUC3
PFSQVPTGEVFYYSC	CFHR1	41	Q03591
YDYEGCPVYFNIIGS	SEC14L4	91	Q9UDX3
PRYFAFAQEYAPCGD	SBK3	111	P0C264
YFTICGLQEGYEPFA	RYR2	1226	Q92736
PDGFLGYPCASYDEF	PNLIPRP2	296	P54317
ASPDGYDCYFDNVGG	PTGR1	206	Q14914
CSTQLGEEPFSYGYG	HNRNPUL1	291	Q9BUJ2
FTEYQYLGSCPGSDG	PPARA	51	Q07869
YACGSAEPSPAYYEF	TMEM255B	166	Q8WV15
CTFGYFDGAYVTLIP	SLC16A12	381	Q6ZSM3
CFEPFVLYFPDYSIG	ORC5	171	O43913
YEPVCGSDGITYFNP	SLCO5A1	566	Q9H2Y9
GCYYPFRTFFGPGVN	SLC41A2	451	Q96JW4
GPHFSCLYPDGVFYD	SPIB	11	Q01892
YYDPKTCGFDFTGAV	GOT2	181	P00505
NCYDVFGAQSPFGGY	ALDH2	471	P05091
YCPFAGYFVESHPSD	CMAHP	251	Q9Y471
DQPGCPTFFYAGYSY	PLA1A	241	Q53H76
PFGDTCFYKHEYPEG	MKRN3	411	Q13064
GEPQYCQYGTPEFVA	SPEG	1751	Q15772
DYTPASGFFPYCSFT	RORA	246	P35398
IYPTEYCSVPGGFDK	PSME4	731	Q14997
DFSGCQGYSEAPGYR	SEC16B	741	Q96JE7